Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...
Ledger-Enquirer on MSN8h
Health Care News: Centricity Research expands footprint in Columbus, GACentricity Research celebrated the opening of its new clinical research facility at 910 Talbotton Rd. in Columbus, Georgia on ...
For Tammy Gusher Delgado, 56, the decision to join a clinical trial was clear. With a recent multiple sclerosis diagnosis and a clinical trial offering either the study drug or an approved ...
The E.mbrace study is a randomized, double-blind, placebo-controlled, multicenter, interventional phase 3 study evaluating the efficacy, safety, and immunogenicity of a single dose of the vaccine ...
GlobalData on MSN6d
MSD commences Phase III trial of DLBCL treatmentMSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...
Martin Friedlander, MD, PhD, discusses phase 3 macular telangiectasia findings, highlighting the potential for a decade-long ...
The Scientific Review Committee (SRC) charter is to review the safety data from the patients treated in the Phase I portion ...
Universities are scrambling after the National Institutes of Health announced a plan to cut millions of dollars in research ...
GH Research PLC (NASDAQ:GHRS) has received an Overweight rating from Cantor Fitzgerald, with a price target set at $14.00. The new coverage is based on the potential of GHRS's GH001, an inhaled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback